European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 58 citations · 24 references
MedicineNuclear MedicineOncologyHybrid ImagingNeuro-oncologyOncologic Nuclear MedicineBrain TumorsGlioblastomaNeuro-oncologic ImagingNeuro-oncology ImagingPositron Emission TomographyTherapy Response AssessmentGlioblastoma Clinical TrialsGlioblastoma Drug TherapyGlioblastoma ImagingGlioblastoma Targeted TherapyGlioblastoma Therapeutic ResistanceLomustine TherapyNeuroimaging Response AssessmentPet Response Criteria
24
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text
Response criteria for phase II studies of supratentorial malignant glioma.
David R. Macdonald, T L Cascino, S. Clifford Schold et al. · Journal of Clinical Oncology · 1990 · 2.4K citations
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Journal of Clinical Oncology · 2007 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick, Thierry Gorlia, Martin Bendszus et al. · New England Journal of Medicine · 2017 · 978 citations · Full text
Medicine, Oncology, Pharmacotherapy +17